PharPoint Research

  • Increase font size
  • Default font size
  • Decrease font size

PharPoint Research Expands Wilmington, NC Office

Chapel Hill, NC, June 25, 2010 - PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it recently leased additional space near the current Wilmington, NC office, allowing for expansion as the business continues to quickly grow.

"We are very excited about the new office space which will allow us to accommodate additional headcount to meet our ever growing business needs,” said Dr. Jennifer Elder, VP, Biostatistics and Consulting and cofounder of PharPoint. Elder continued “We are experiencing an increase in our repeat business rate and the addition of new clients is on the rise for 2010. This expansion is necessary to continue to meet our client’s needs in an efficient and effective manner which has always been the hallmark of PharPoint’s superior customer service.”

The new office is approximately 4500 square feet which is triple the size of the current Wilmington office. PharPoint plans to utilize the additional space to increase headcount in its biostatistics department. Employees will begin moving into the new office in July.

About PharPoint Research

PharPoint Research, Inc. is a niche pharmaceutical development service provider specializing in data management and biostatistics. Our staff has worked together for over a decade and includes some of the most talented professionals in the industry. PharPoint understands the importance of responsiveness and timely deliverables with exceptional quality. We pride ourselves on years of experience, superb repeat client rate and the ability to consistently exceed our client’s expectations. Founded in 2006, PharPoint is headquartered in Chapel Hill, NC near Research Triangle Park. For more information, visit www.pharpoint.com.

Contact:

PharPoint Research, Inc
Carmen Hogan
919.929.0012
This e-mail address is being protected from spambots. You need JavaScript enabled to view it